JP2025516335A5 - - Google Patents

Info

Publication number
JP2025516335A5
JP2025516335A5 JP2024565103A JP2024565103A JP2025516335A5 JP 2025516335 A5 JP2025516335 A5 JP 2025516335A5 JP 2024565103 A JP2024565103 A JP 2024565103A JP 2024565103 A JP2024565103 A JP 2024565103A JP 2025516335 A5 JP2025516335 A5 JP 2025516335A5
Authority
JP
Japan
Prior art keywords
crystal
degrees
approximately
diffraction pattern
ray powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024565103A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025516335A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/020428 external-priority patent/WO2023215196A1/en
Publication of JP2025516335A publication Critical patent/JP2025516335A/ja
Publication of JP2025516335A5 publication Critical patent/JP2025516335A5/ja
Pending legal-status Critical Current

Links

JP2024565103A 2022-05-03 2023-04-28 オートタキシン阻害剤の多形形態 Pending JP2025516335A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263364065P 2022-05-03 2022-05-03
US63/364,065 2022-05-03
PCT/US2023/020428 WO2023215196A1 (en) 2022-05-03 2023-04-28 Polymorphic and salt forms of the autotaxin inhibitor cudetaxestat

Publications (2)

Publication Number Publication Date
JP2025516335A JP2025516335A (ja) 2025-05-27
JP2025516335A5 true JP2025516335A5 (cg-RX-API-DMAC10.html) 2026-05-11

Family

ID=88646878

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024565103A Pending JP2025516335A (ja) 2022-05-03 2023-04-28 オートタキシン阻害剤の多形形態

Country Status (7)

Country Link
US (1) US20250282759A1 (cg-RX-API-DMAC10.html)
EP (1) EP4519253A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025516335A (cg-RX-API-DMAC10.html)
CN (1) CN120112527A (cg-RX-API-DMAC10.html)
AU (1) AU2023265017A1 (cg-RX-API-DMAC10.html)
CA (1) CA3251769A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023215196A1 (cg-RX-API-DMAC10.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20160654A1 (es) * 2013-11-22 2016-07-15 Pharmakea Inc Compuestos de inhibidor de autotaxina
CN116059203A (zh) * 2015-05-27 2023-05-05 赛博治疗有限责任公司 自分泌运动因子抑制剂及其用途

Similar Documents

Publication Publication Date Title
JP2023036708A5 (cg-RX-API-DMAC10.html)
JP2024071370A5 (cg-RX-API-DMAC10.html)
CN101573368B (zh) 结晶型1-(β-D-吡喃葡糖基)-4-甲基-3-[5-(4-氟苯基)-2-噻吩基甲基]苯半水合物
JP2023519891A5 (cg-RX-API-DMAC10.html)
JP2024105460A5 (cg-RX-API-DMAC10.html)
JP2021530565A5 (cg-RX-API-DMAC10.html)
JP2022502500A5 (cg-RX-API-DMAC10.html)
JP2024516371A5 (cg-RX-API-DMAC10.html)
JP2023511105A5 (cg-RX-API-DMAC10.html)
JP2023082086A5 (cg-RX-API-DMAC10.html)
JP2021504338A5 (cg-RX-API-DMAC10.html)
JP2013538849A5 (cg-RX-API-DMAC10.html)
RU2013145518A (ru) Твердые формы 3-(5-амино-2-метил-4-оксо-4н-хиназолин-3-ил)пиперидин-2, 6-диона и их фармацевтические композиции и применение
JP2023027066A5 (cg-RX-API-DMAC10.html)
JP2017527578A5 (cg-RX-API-DMAC10.html)
JP2009535340A5 (cg-RX-API-DMAC10.html)
JP2019504103A5 (cg-RX-API-DMAC10.html)
HRP20150062T1 (hr) Farmaceutski pripravak koji sadrži optički aktivan spoj koji sadrži agonist receptora trombopoietina i njegov međuprodukt
JP2020528913A5 (cg-RX-API-DMAC10.html)
RU2015134420A (ru) Кристаллические формы { [1-циано-5-(4-хлорофеноксид)-4-гидроксид-изохинолин-3-карбонил]-амино} -уксусной кислоты
JP2023109937A5 (cg-RX-API-DMAC10.html)
JP2022523368A5 (cg-RX-API-DMAC10.html)
JP2024045113A5 (cg-RX-API-DMAC10.html)
JP2024544538A5 (cg-RX-API-DMAC10.html)
JP2023523770A5 (cg-RX-API-DMAC10.html)